Per Falholt founded the company in 2016 to offer Advisory Services within R&D/Innovation, Talent Development and Relationship Building.
Clients include Corbion, Novozymes, Generation and the Novo Nordisk Foundation. Per chairs the Board of Governors at the Technical University of Denmark (DTU) and the Science and Engineering Committee of The Danish Academy of Technical Sciences (ATV).
He is also a member of the Advisory Council of Emerald Technology Ventures AG.
In 2017 Per joined the Danfoss A/S Board and the Board of Universe Science Park.
He holds numerous positions of trust within the biotech area at boards, councils and committees including Cytovac (immunotherapy), Young Scientists Awards, Synapse (forum for students and young professionals within life sciences), AgroSpheres (environmentally friendly biotech solutions) and CiBO Technologies (sustainable agronomy).
Per has had a long and successful career at Novo Nordisk A/S and Novozymes A/S.
In 2000 he assumed the position as the Executive Vice President of Research and Development at Novozymes and helped the company develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.
Per started his career at Novo A/S in 1984 as a research chemist and subsequently held several managerial positions in Novo Nordisk A/S. In 1997 he moved to Raleigh, N.C., to head the company’s U.S. application technology unit, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division.
Over the years Per Falholt has been a driving force in multiple initiatives to foster talents and enhance science education in Denmark.
Per’s expertise areas include New Products Development, Research & Innovation, Patent and Regulatory issues and R&D strategies. He holds an M.Sc. in Chemical Engineering from the Technical University of Denmark and attended a business program at IMD (International Institute for Management Development) in Lausanne.